Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and peptide phi

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with peptide phi in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(peptide phi)		Trials
(peptide phi)		Recent Studies (post-2010) (peptide phi)
9,15618755248258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Marzo, V; Morris, HR; Tippins, JR1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and peptide phi

ArticleYear
Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung.
    Neuropeptides, 1987, Volume: 9, Issue:1

    Topics: Animals; In Vitro Techniques; Leukotriene E4; Lung; Male; Peptide PHI; Platelet Activating Factor; Rats; Rats, Inbred Strains; Secretin; SRS-A

1987